PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS

被引：0
|
作者：
Boven, E. [1 ]
Massard, C. [2 ]
Armand, J. P. [3 ]
Tillier, C. [1 ]
Hartog, V. [1 ]
Brega, N. M. [4 ]
Contouriotis, A. M. [5 ]
Law, C. N. J. [5 ]
Soria, J. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Inst Gustave Roussy, Villejuif, France
[3] Inst Claudius Regaud, Toulouse, France
[4] Pfizer Global Res & Dev, Oncology, Milan, Italy
[5] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [1] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
  • [2] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [3] Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
    Michaelson, M. D.
    Zhu, A. X.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Stephenson, P.
    Patyna, S.
    Ruiz-Garcia, A.
    Schwarzberg, A. B.
    BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1393 - 1401
  • [4] Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
    M D Michaelson
    A X Zhu
    D P Ryan
    D F McDermott
    G I Shapiro
    L Tye
    I Chen
    P Stephenson
    S Patyna
    A Ruiz-Garcia
    A B Schwarzberg
    British Journal of Cancer, 2013, 108 : 1393 - 1401
  • [5] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] A PHASE I DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D.
    McDermott, D.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [7] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Pierre Fumoleau
    Jose Manuel Trigo
    Nicolas Isambert
    Dorothée Sémiond
    Sunil Gupta
    Mario Campone
    BMC Cancer, 13
  • [8] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Fumoleau, Pierre
    Trigo, Jose Manuel
    Isambert, Nicolas
    Semiond, Dorothee
    Gupta, Sunil
    Campone, Mario
    BMC CANCER, 2013, 13
  • [9] Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study
    Chiorean, E. G.
    Sweeney, C. J.
    Verschraegen, C. F.
    Lee, F. C.
    Jones, S. F.
    Rabinowitz, I.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors
    Kuppens, IELM
    Dansin, E
    Boot, H
    Feger, C
    Assadourian, S
    Bonneterre, ME
    Beijnen, JH
    Schellens, JHM
    Bonneterre, J
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3774 - 3781
12345